about
Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in HumansExplicit and implicit emotional expression in bulimia nervosa in the acute state and after recovery.Executive functions profile in extreme eating/weight conditions: from anorexia nervosa to obesity.Changes in Body Composition in Anorexia Nervosa: Predictors of Recovery and Treatment OutcomeA Serious Videogame as an Additional Therapy Tool for Training Emotional Regulation and Impulsivity Control in Severe Gambling Disorder.Treatment Outcome in Male Gambling Disorder Patients Associated with Alcohol Use.Compulsive Buying Behavior: Characteristics of Comorbidity with Gambling Disorder.Compulsive Buying Behavior: Clinical Comparison with Other Behavioral Addictions.Modulation of Irisin and Physical Activity on Executive Functions in Obesity and Morbid obesity.A Spanish Validation of the Canadian Adolescent Gambling Inventory (CAGI).Compulsive buying disorder clustering based on sex, age, onset and personality traits.[Fair use of tests in health sciences].Smell-taste dysfunctions in extreme weight/eating conditions: analysis of hormonal and psychological interactions.Exploring the Relationship between Reward and Punishment Sensitivity and Gambling Disorder in a Clinical Sample: A Path Modeling Analysis.The Influence of Personality Traits on Emotion Expression in Bulimic Spectrum Disorders: A Pilot Study.Orexin and sleep quality in anorexia nervosa: Clinical relevance and influence on treatment outcome.Mediational Role of Age of Onset in Gambling Disorder, a Path Modeling Analysis.Predictors of Outcome among Pathological Gamblers Receiving Cognitive Behavioral Group Therapy
P50
Q28533998-5BBBBC00-5AC5-4919-8677-9A9EABE0AE92Q30435233-6720940D-7EC0-497E-B073-02B2C462D2E1Q34395675-3699B336-F963-4A25-B87A-47D2464557C2Q35850797-9C86E309-0776-4ADD-AA94-C31448817938Q36271873-DE231863-EFC1-4ED0-AC6E-D898D56F9B77Q36750038-25374B46-7A13-4918-B74E-8C165ACB0D8CQ36851010-796041F5-5607-4240-89DE-6396F800ECDAQ37004902-A024CFAC-4373-4014-8BC4-3E1060139C1BQ37141128-229439AC-A7E1-4577-9FA0-034AF79343D2Q37627194-9BBCDBDF-767E-409A-B9EF-7C4F08AB0CC5Q40731902-76F00541-E3B9-404B-AE02-29E7193DDED6Q45013373-3A90C1AB-15E9-4185-8302-78B336F69160Q47373499-9FCC35BE-F958-41C4-A54F-E20A9E37ABE5Q47411041-D1FE588B-548A-407F-9251-11A293434741Q47445781-D5FE467C-51EB-4ACA-931C-F2FD759E247AQ47901433-37EDD088-7EB4-4F46-A173-FD6FE64B5CD1Q48088057-2C2632AA-08BA-4CD9-A30C-F3613DABD763Q58039319-6B07765E-AE65-4CA2-B538-686E17135DBE
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Salomé Tárrega
@en
Salomé Tárrega
@nl
type
label
Salomé Tárrega
@en
Salomé Tárrega
@nl
prefLabel
Salomé Tárrega
@en
Salomé Tárrega
@nl
P31
P496
0000-0002-5820-6795